Literature DB >> 30211798

Current Update on Desmoid Fibromatosis.

Dhakshinamoorthy Ganeshan1, Behrang Amini2, Paul Nikolaidis3, Matthew Assing4, Raghunandan Vikram2.   

Abstract

OBJECTIVE: The purpose of this article is to review the etiopathogenesis, molecular cytogenetics, histopathology, clinical features, and multimodality imaging features of desmoid fibromatosis. Recent advances in the management of desmoid fibromatosis will also be discussed.
CONCLUSIONS: Desmoid fibromatosis is a rare soft tissue neoplasm with a high incidence of local recurrence. Imaging plays an important role in the diagnosis and management of this disease.

Entities:  

Mesh:

Year:  2019        PMID: 30211798      PMCID: PMC6331223          DOI: 10.1097/RCT.0000000000000790

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  17 in total

1.  Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.

Authors:  Chuanxi Zheng; Jianguo Fang; Yitian Wang; Yong Zhou; Chongqi Tu; Li Min
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-15       Impact factor: 4.553

Review 2.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

3.  Differentiation of intra-abdominal desmoid tumor from peritoneal seeding based on CT and/or 18F-FDG PET-CT in patients with history of cancer surgery.

Authors:  June Suh; Hyo-Jin Kang; Se Hyung Kim
Journal:  Abdom Radiol (NY)       Date:  2020-06-19

4.  MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis.

Authors:  Ty K Subhawong; Katharina Feister; Kevin Sweet; Noam Alperin; Deukwoo Kwon; Andrew Rosenberg; Jonathan Trent; Breelyn A Wilky
Journal:  Radiol Imaging Cancer       Date:  2021-07

5.  A rare case of infantile desmoid-type fibromatosis on the thigh.

Authors:  Shuaihantian Luo; Guilin Tang; Guiying Zhang
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

6.  Metachronous Sporadic Desmoid Tumors Arisen in the Stomach and the Cecum.

Authors:  Ichiro Tamaki; Hidenori Takahara
Journal:  Cureus       Date:  2021-05-04

7.  The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution.

Authors:  Chuanxi Zheng; Yong Zhou; Yitian Wang; Yi Luo; Chongqi Tu; Li Min
Journal:  Drug Des Devel Ther       Date:  2020-09-25       Impact factor: 4.162

8.  MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis.

Authors:  Hui Ci Zhu; Shi Xing Xu; Xiao Ting Li; Zhen Guan; Shu Li; Ying-Shi Sun
Journal:  Front Oncol       Date:  2021-03-15       Impact factor: 6.244

9.  The Management of Desmoid Tumors: A Retrospective Study of 30 Cases.

Authors:  Yosr Zenzri; Yosra Yahyaoui; Lamia Charfi; Zahra Ghodhbani; Feryel Letaief; Mouna Ayadi; Amel Mezlini
Journal:  Int J Surg Oncol       Date:  2020-07-18

10.  Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis.

Authors:  Ikram A Burney; Anupam K Kakaria; Suad Al-Jahdhami
Journal:  Sultan Qaboos Univ Med J       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.